FDA approves 1st cheaper version of J&J's top drug Remicade 0 05.04.2016 23:57 McClatchy DC Bureau Federal health officials have approved a cheaper version of Johnson & Johnson's top-selling drug, Remicade, a pricey biotech medicine for inflammatory diseases. … Click to Continue » Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
